×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AMPH – amphastar pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AMPH
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/16
05:41 am
amph
2 Reasons to Avoid AMPH and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
2 Reasons to Avoid AMPH and 1 Stock to Buy Instead [Yahoo! Finance]
1/15
04:03 pm
amph
Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving [Yahoo! Finance]
Low
Report
Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving [Yahoo! Finance]
1/12
05:53 pm
amph
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today [Yahoo! Finance]
Low
Report
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today [Yahoo! Finance]
1/12
06:17 am
amph
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound [Yahoo! Finance]
Medium
Report
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound [Yahoo! Finance]
12/23
10:32 am
amph
Amphastar Director Sells 16,679 Shares for $441,800 [Yahoo! Finance]
Low
Report
Amphastar Director Sells 16,679 Shares for $441,800 [Yahoo! Finance]
12/16
11:30 am
amph
Will FDA Approval of an In-House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative? [Yahoo! Finance]
Low
Report
Will FDA Approval of an In-House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative? [Yahoo! Finance]
12/16
07:37 am
amph
Amphastar: Baqsimi Props Up Flat Growth, But 2026 Guidance Looks Fragile [Seeking Alpha]
Low
Report
Amphastar: Baqsimi Props Up Flat Growth, But 2026 Guidance Looks Fragile [Seeking Alpha]
12/12
07:05 pm
amph
2 Russell 2000 Stocks for Long-Term Investors and 1 Facing Challenges [Yahoo! Finance]
Medium
Report
2 Russell 2000 Stocks for Long-Term Investors and 1 Facing Challenges [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2025
04:05 pm
AMPH
amphastar pharmaceuticals, inc.
BEAT
Report
-0.8%
amphastar pharmaceuticals, inc.
8/7/2025
04:05 pm
AMPH
amphastar pharmaceuticals, inc.
BEAT
Report
8.2%
amphastar pharmaceuticals, inc.
5/7/2025
04:05 pm
AMPH
amphastar pharmaceuticals, inc.
BEAT
Report
0.9%
amphastar pharmaceuticals, inc.
5/7/2025
04:05 pm
AMPH
amphastar pharmaceuticals, inc.
BEAT
Report
0.9%
amphastar pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/12
05:15 pm
amph
Form 8-K Amphastar Pharmaceutical For: Jan 06
Low
Report
Form 8-K Amphastar Pharmaceutical For: Jan 06
12/18
05:23 pm
amph
Form 4 Amphastar Pharmaceutical For: Dec 17 Filed by: Zhou Rong
Low
Report
Form 4 Amphastar Pharmaceutical For: Dec 17 Filed by: Zhou Rong
12/15
05:18 pm
amph
Form 4 Amphastar Pharmaceutical For: Dec 11 Filed by: Petersen Floyd F.
Low
Report
Form 4 Amphastar Pharmaceutical For: Dec 11 Filed by: Petersen Floyd F.
12/11
05:18 pm
amph
Form 144 Amphastar Pharmaceutical Filed by: Petersen Floyd F.
Low
Report
Form 144 Amphastar Pharmaceutical Filed by: Petersen Floyd F.
12/10
02:40 pm
amph
Form 144 Amphastar Pharmaceutical Filed by: Petersen Floyd F.
Low
Report
Form 144 Amphastar Pharmaceutical Filed by: Petersen Floyd F.
11/28
01:23 pm
amph
Form 144 Amphastar Pharmaceutical Filed by: Zhou Rong
Neutral
Report
Form 144 Amphastar Pharmaceutical Filed by: Zhou Rong
11/25
07:39 pm
amph
Form 4 Amphastar Pharmaceutical For: Nov 25 Filed by: PRINS RICHARD K
Low
Report
Form 4 Amphastar Pharmaceutical For: Nov 25 Filed by: PRINS RICHARD K
11/25
05:05 pm
amph
Form 144 Amphastar Pharmaceutical Filed by: PRINS RICHARD K
Low
Report
Form 144 Amphastar Pharmaceutical Filed by: PRINS RICHARD K
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Form 10-K Amphastar Pharmaceutical For: Dec 31
11.3%
4/27 Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial 7.5%
8/7 Q2/2019 6/30/2019 EPS 0.080 ZacksConsensus 0.030 ActVsEst 0.050 - Beat 7.0%
11/8 Amphastar Pharmaceuticals Inc (AMPH) Q3 2019 Earnings Call Transcript [The Motley Fool] 4.9%
3/18 Form 4 Amphastar Pharmaceutical For: Mar 16 Filed by: Liawatidewi Yakob 4.5%
3/3 Form 4 Amphastar Pharmaceutical For: Mar 02 Filed by: Petersen Floyd F. 3.9%
4/9 Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference 3.8%
8/16 Form 4 Amphastar Pharmaceutical For: Aug 15 Filed by: PETERS WILLIAM J 3.4%
9/9 Form 4 Amphastar Pharmaceutical For: Sep 05 Filed by: Liawatidewi Yakob 3.1%
3/12 Q4/2019 12/31/2019 EPS 0.070 ZacksConsensus 0.050 ActVsEst 0.020 - Beat 2.3%
4/27 Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial 7.5%
8/7 Q2/2019 6/30/2019 EPS 0.080 ZacksConsensus 0.030 ActVsEst 0.050 - Beat 7.0%
11/8 Amphastar Pharmaceuticals Inc (AMPH) Q3 2019 Earnings Call Transcript [The Motley Fool] 4.9%
3/18 Form 4 Amphastar Pharmaceutical For: Mar 16 Filed by: Liawatidewi Yakob 4.5%
3/3 Form 4 Amphastar Pharmaceutical For: Mar 02 Filed by: Petersen Floyd F. 3.9%
4/9 Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference 3.8%
8/16 Form 4 Amphastar Pharmaceutical For: Aug 15 Filed by: PETERS WILLIAM J 3.4%
9/9 Form 4 Amphastar Pharmaceutical For: Sep 05 Filed by: Liawatidewi Yakob 3.1%
3/12 Q4/2019 12/31/2019 EPS 0.070 ZacksConsensus 0.050 ActVsEst 0.020 - Beat 2.3%
TOP News Decliners
3/17
Form 4 Amphastar Pharmaceutical For: Mar 15 Filed by: Zhou Rong
-11.9%
3/12 Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -9.3%
2/28 Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -9.3%
3/13 Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $16.00 price target on the stock. -8.2%
11/7 Form 8-K Amphastar Pharmaceutical For: Nov 07 -8.0%
5/31 Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference -7.3%
5/12 Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -6.8%
11/8 Form 10-Q Amphastar Pharmaceutical For: Sep 30 -5.8%
1/29 Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. -3.1%
6/10 Form 4 Amphastar Pharmaceutical For: Jun 07 Filed by: Lee Howard -3.1%
3/12 Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -9.3%
2/28 Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -9.3%
3/13 Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $16.00 price target on the stock. -8.2%
11/7 Form 8-K Amphastar Pharmaceutical For: Nov 07 -8.0%
5/31 Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference -7.3%
5/12 Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -6.8%
11/8 Form 10-Q Amphastar Pharmaceutical For: Sep 30 -5.8%
1/29 Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. -3.1%
6/10 Form 4 Amphastar Pharmaceutical For: Jun 07 Filed by: Lee Howard -3.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: